Unknown

Dataset Information

Modulating hydrogel crosslink density and degradation to control bone morphogenetic protein delivery and in vivo bone formation.


ABSTRACT: Bone morphogenetic proteins (BMPs) show promise in therapies for improving bone formation after injury; however, the high supraphysiological concentrations required for desired osteoinductive effects, off-target concerns, costs, and patient variability have limited the use of BMP-based therapeutics. To better understand the role of biomaterial design in BMP delivery, a matrix metalloprotease (MMP)-sensitive hyaluronic acid (HA)-based hydrogel was used for BMP-2 delivery to evaluate the influence of hydrogel degradation rate on bone repair in vivo. Specifically, maleimide-modified HA (MaHA) macromers were crosslinked with difunctional MMP-sensitive peptides to permit protease-mediated hydrogel degradation and growth factor release. The compressive, rheological, and degradation properties of

SUBMITTER: Holloway JL 

PROVIDER: S-EPMC4156908 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature